U.S. Physical Therapy (NYSE:USPH) Director Purchases $17,712.00 in Stock

Posted by Geri Gentry on Jun 13th, 2026

U.S. Physical Therapy, Inc. (NYSE:USPH – Get Free Report) Director Peter Francis Minan purchased 288 shares of the company’s stock in a transaction dated Tuesday, June 9th. The shares were acquired at an average price of $61.50 per share, for a total transaction of $17,712.00. Following the purchase, the director directly owned 3,211 shares in the company, valued at approximately $197,476.50. The trade was a 9.85% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Peter Francis Minan also recently made the following trade(s):

On Monday, June 8th, Peter Francis Minan purchased 492 shares of U.S. Physical Therapy stock. The shares were acquired at an average price of $63.14 per share, for a total transaction of $31,064.88.

U.S. Physical Therapy Trading Down 0.2%

Shares of U.S. Physical Therapy stock opened at $65.66 on Friday. The company’s fifty day simple moving average is $68.21 and its 200-day simple moving average is $76.26. The stock has a market capitalization of $999.35 million, a PE ratio of 131.32, a P/E/G ratio of 1.82 and a beta of 1.16. U.S. Physical Therapy, Inc. has a 1-year low of $58.19 and a 1-year high of $93.50. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.19 and a quick ratio of 1.19.

U.S. Physical Therapy (NYSE:USPH – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.46 EPS for the quarter, missing the consensus estimate of $0.55 by ($0.09). The firm had revenue of $198.29 million for the quarter, compared to the consensus estimate of $200.94 million. U.S. Physical Therapy had a net margin of 4.36% and a return on equity of 8.81%. The firm’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.48 earnings per share. As a group, equities analysts anticipate that U.S. Physical Therapy, Inc. will post 2.99 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, June 12th. Stockholders of record on Friday, May 22nd were given a dividend of $0.46 per share. This represents a $1.84 annualized dividend and a dividend yield of 2.8%. The ex-dividend date was Friday, May 22nd. U.S. Physical Therapy’s dividend payout ratio (DPR) is presently 368.00%.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the stock. Jefferies Financial Group upgraded shares of U.S. Physical Therapy to a “strong-buy” rating in a research report on Thursday, March 12th. Zacks Research upgraded shares of U.S. Physical Therapy from a “strong sell” rating to a “hold” rating in a research report on Wednesday, May 27th. Barrington Research decreased their price objective on shares of U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating on the stock in a research report on Wednesday, May 13th. Weiss Ratings restated a “hold (c-)” rating on shares of U.S. Physical Therapy in a research report on Friday, May 29th. Finally, Citizens Jmp decreased their price objective on shares of U.S. Physical Therapy from $113.00 to $98.00 and set a “market outperform” rating on the stock in a research report on Friday, May 8th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have issued a Hold rating to the company’s stock. According to data from MarketBeat, U.S. Physical Therapy presently has a consensus rating of “Moderate Buy” and an average target price of $97.50.

Read Our Latest Report on U.S. Physical Therapy

Institutional Trading of U.S. Physical Therapy

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Vanguard Group Inc. increased its holdings in U.S. Physical Therapy by 1.5% in the 4th quarter. Vanguard Group Inc. now owns 1,085,336 shares of the company’s stock valued at $84,754,000 after acquiring an additional 15,712 shares during the last quarter. Copeland Capital Management LLC increased its holdings in U.S. Physical Therapy by 6.5% in the 1st quarter. Copeland Capital Management LLC now owns 836,831 shares of the company’s stock valued at $62,729,000 after acquiring an additional 50,717 shares during the last quarter. Bank of America Corp DE increased its holdings in U.S. Physical Therapy by 10.9% in the 1st quarter. Bank of America Corp DE now owns 554,621 shares of the company’s stock valued at $41,574,000 after acquiring an additional 54,656 shares during the last quarter. Dimensional Fund Advisors LP increased its holdings in U.S. Physical Therapy by 3.2% in the 1st quarter. Dimensional Fund Advisors LP now owns 507,394 shares of the company’s stock valued at $38,035,000 after acquiring an additional 15,668 shares during the last quarter. Finally, Bahl & Gaynor Inc. increased its holdings in U.S. Physical Therapy by 47.6% in the 3rd quarter. Bahl & Gaynor Inc. now owns 474,688 shares of the company’s stock valued at $40,325,000 after acquiring an additional 153,054 shares during the last quarter.

U.S. Physical Therapy Company Profile

(Get Free Report)

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.